Participants receiving semaglutide 7.2 mg achieved 20.7% average weight reduction, with 33% of patients losing more than 25% of their body weight ^1
Where legitimate informational advertising ends and misleading promotion begins will likely be tested further as this enforcement campaign progresses
[DOI] [PMC free article] [PubMed] [Google Scholar] 165.Vijiaratnam N, et al
Though moderate gastrointestinal side effects, e.g., nausea or diarrhea, may occur at greater doses, myo-inositol generally has a favorable safety profile, with daily intakes up to 12 g being regarded as well-tolerated [42]
prausnitzii, and Lactobacillus spp., is advisable, with parallel attention to the overgrowth of proinflammatory taxa like Proteobacteria